Gary V. Burton

2.1k total citations
68 papers, 1.5k citations indexed

About

Gary V. Burton is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gary V. Burton has authored 68 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 22 papers in Cancer Research and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gary V. Burton's work include Breast Cancer Treatment Studies (17 papers), Cancer Treatment and Pharmacology (11 papers) and Brain Metastases and Treatment (8 papers). Gary V. Burton is often cited by papers focused on Breast Cancer Treatment Studies (17 papers), Cancer Treatment and Pharmacology (11 papers) and Brain Metastases and Treatment (8 papers). Gary V. Burton collaborates with scholars based in United States, France and Canada. Gary V. Burton's co-authors include Runhua Shi, Benjamin D.�L. Li, Quyen D. Chu, Glenn Mills, Edwin B. Cox, Federico L. Ampil, Danika L. Lew, Richard Mansour, David F. Lewis and George S. Leight and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

Gary V. Burton

67 papers receiving 1.4k citations

Peers

Countries citing papers authored by Gary V. Burton

Since Specialization

Citations

This map shows the geographic impact of Gary V. Burton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary V. Burton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary V. Burton more than expected).

Fields of papers citing papers by Gary V. Burton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary V. Burton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary V. Burton. The network helps show where Gary V. Burton may publish in the future.

Co-authorship network of co-authors of Gary V. Burton

This figure shows the co-authorship network connecting the top 25 collaborators of Gary V. Burton. A scholar is included among the top collaborators of Gary V. Burton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary V. Burton. Gary V. Burton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Regression of a glioblastoma multiforme: spontaneous versus a potential antineoplastic effect of dexamethasone and levetiracetam 2016 ·BMJ Case Reports ·Prakash Peddi, (unknown), Gary V. Burton, Hazem El‐Osta	10
2	Effects of payer status on breast cancer survival: a retrospective study 2015 ·BMC Cancer ·Runhua Shi, Hannah Taylor, Jerry McLarty, Lihong Liu, Glenn Mills, Gary V. Burton	52
3	Does obesity have an effect on outcomes in triple-negative breast cancer? 2013 ·Journal of Surgical Research ·(unknown), Quyen D. Chu, Benjamin D.�L. Li, Gary V. Burton, (unknown), Roger H. Kim	48
4	Should a Routine Metastatic Workup Be Performed for all Patients with Pathologic N2/N3 Breast Cancer? 2012 ·Journal of the American College of Surgeons ·Quyen D. Chu, Amanda Henderson, Roger H. Kim, Karen J. Miller, Gary V. Burton, (unknown), Benjamin D.�L. Li	4
5	Osteonecrosis of the Jaw in Patients with Metastatic Breast Cancer: Ethnic and Socio-Economic Aspects 2011 ·The Breast Journal ·(unknown), Runhua Shi, Gary V. Burton	21
6	Impact of Race and Ethnicity on Outcomes for Estrogen Receptor-Negative Breast Cancers: Experience of an Academic Center with a Charity Hospital 2010 ·Journal of the American College of Surgeons ·Quyen D. Chu, Gary V. Burton, Jonathan Glass, Mark H. Smith, Benjamin D.�L. Li	12
7	Carcinomatous Meningitis Secondary to Transitional Cell Bladder Cancer 2010 ·Southern Medical Journal ·(unknown), Gary V. Burton, (unknown), Phillip Madonia, (unknown), (unknown), Richard M. Zweig, Chaitanya Pant	3
8	Wernicke Encephalopathy Complicating Lymphoma Therapy: Case Report and Literature Review 2007 ·Southern Medical Journal ·(unknown), Molly Boyd, (unknown), Gary V. Burton	14
9	Phase II Trial of Gemcitabine as First Line Chemotherapy in Patients With Metastatic or Unresectable Soft Tissue Sarcoma 2006 ·American Journal of Clinical Oncology ·Gary V. Burton, (unknown), Mark M. Zalupski, (unknown), Ernest C. Borden, (unknown)	32
10	Primary Intracranial Leiomyosarcoma: Report of a Case and Review of the Literature 2006 ·Sarcoma ·(unknown), Anil Nanda, Marjorie Fowler, Federico L. Ampil, Gary V. Burton	27
11	Ototoxicity of cisplatin plus standard radiation therapy vs. accelerated radiation therapy in glioblastoma patients 2005 ·Journal of Neuro-Oncology ·Nicole Marshall, Karla V. Ballman, John C. Michalak, Paula J. Schomberg, Gary V. Burton, Howard M. Sandler, Terrence L. Cascino, Kurt A. Jaeckle, Jan C. Buckner	22
12	Radical combined treatment of locally extensive head and neck cancer in the elderly 2001 ·American Journal of Otolaryngology ·Federico L. Ampil, Glenn Mills, Fred J. Stucker, Gary V. Burton, Cherie‐Ann O. Nathan	12
13	Efficacy of Oral Ondansetron, A Selective Antagonist of 5-HT3 Receptors, in the Treatment of Nausea and Vomiting Associated with Cyclophosphamide-Based Chemotherapies 1994 ·American Journal of Clinical Oncology ·Luigi X. Cubeddu, Kelly Pendergrass, Thomas Ryan, (unknown), Gary V. Burton, Michael W. Meshad, Daniel Galvin	30
14	Case Report: Retinitis Pigmentosa Following Cytotoxic Chemotherapy in Usher’s Syndrome 1992 ·The American Journal of the Medical Sciences ·(unknown), (unknown), Gary V. Burton	5
15	A phase I/II study of combined cisplatin and hyperthermia treatment for refractory malignancy 1989 ·International Journal of Hyperthermia ·Daniel M. Green, Gary V. Burton, Edwin B. Cox, (unknown), Joseph O. Moore, James R. Oleson	20
16	Cisplatin and Etoposide: An Effective Treatment for Refractory Breast Carcinoma 1989 ·American Journal of Clinical Oncology ·Edwin B. Cox, Gary V. Burton, Gregg A. Olsen, Davor Vugrin	22
17	Diabetic autonomic neuropathy—part I 1988 ·The American Journal of Medicine ·M. Schumer, Gary V. Burton, (unknown), (unknown), Roman Pfeifer	22
18	Paraneoplastic limbic encephalopathy with testicular carcinoma: A reversible neurologic syndrome 1988 ·Cancer ·Gary V. Burton, Dennis E. Bullard, Philip Walther, Peter C. Burger	43
19	Estrogen receptor determination by monoclonal antibody in fine needle aspiration breast cancer cytologies: A marker of hormone response 1987 ·Breast Cancer Research and Treatment ·Gary V. Burton, Julie L. Flowers, Edwin B. Cox, George S. Leight, Georgette A. Dent, Kim R. Geisinger, Kenneth S. McCarty	10
20	Inflammatory Breast Carcinoma 1987 ·Archives of Surgery ·Gary V. Burton	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact